Clinical Trials Logo

Filter by:
NCT ID: NCT03898973 Withdrawn - Influenza Clinical Trials

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood

FLU-LN
Start date: April 11, 2019
Phase: Phase 4
Study type: Interventional

This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to determine how immune memory develops at the actual site of exposure, and how immunization may alter this process.

NCT ID: NCT03897725 Withdrawn - HIV/AIDS Clinical Trials

Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This project is designed to 1) develop a PrEP implementation plan for a general adolescent clinic. Investigators will develop a replicable implementation plan for providing PrEP to adolescents in a primary care setting; and 2) Determine the acceptability and preliminary effectiveness of a telehealth intervention to promote adherence in adolescents.

NCT ID: NCT03894319 Withdrawn - Back Pain Clinical Trials

Use of Lumbar Motion Monitor to Predict Response to Radiofrequency Ablation After Medial Branch Diagnostic Blocks

Start date: June 6, 2018
Phase:
Study type: Observational

The study is being performed to determine if adding an objective measurement of back function can assess the success of a commonly performed back injection procedure-lumbar medial branch blocks. Researchers also hope to compare whether those who have objective improvements after lumbar medial branch blocks will also have more successful lumbar medial branch radiofrequency ablation.

NCT ID: NCT03894098 Withdrawn - Ankle Surgery Clinical Trials

High Ankle Block Versus Regional Block for Acute Pain Control After Ankle Surgery

Start date: March 26, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if a high ankle block during ankle surgery provides the same pain relief as the standard regional block.

NCT ID: NCT03893292 Withdrawn - Postoperative Pain Clinical Trials

Preop Cooled Radiofrequency Ablation for Total Knee Replacement

Start date: January 24, 2019
Phase:
Study type: Observational

Total knee replacement surgery is commonly performed for patients suffering from severe knee osteoarthritis. However, 20% of patients continue to experience pain after surgery. There is currently no standardized pain management protocol for pain after total knee replacement. Cooled radiofrequency ablation has been used successfully to alleviate spin-related pain and has recently been approved by the FDA to treat chronic knee arthritic pain. This pilot study aims to collect preliminary data on the use of cooled radiofrequency ablation in patients undergoing total knee replacement.

NCT ID: NCT03891979 Withdrawn - Pancreatic Cancer Clinical Trials

Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma

Start date: June 25, 2019
Phase: Phase 4
Study type: Interventional

A multi-institutional, single arm pilot study of antibiotics and pembrolizumab for the treatment of surgically resectable pancreatic cancer. The primary purpose of this study is to determine the change in immune activation in pancreatic tumor tissue following treatment with antibiotics and pembrolizumab.

NCT ID: NCT03891602 Withdrawn - Lung Cancer Clinical Trials

DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement

DECIDE
Start date: March 22, 2019
Phase:
Study type: Observational

The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.

NCT ID: NCT03890341 Withdrawn - Healthy Clinical Trials

Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440

Start date: June 1, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of JNJ-64530440 single- and multiple-dose administration on the single-dose pharmacokinetics of drospirenone and ethinylestradiol (oral contraceptive) in healthy female participants.

NCT ID: NCT03889600 Withdrawn - Clinical trials for Diabetes Mellitus, Type 2

Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

Over 27 million Americans are diagnosed with Type 2 Diabetes Mellitus (T2DM), and their health outcomes, including hospitalization, emergency department use, and hospital readmission, are largely driven by social determinants; diabetes complications are largely attributable to unmet health-related social needs. Investigators will conduct a pilot feasibility trial of the Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT) system to inform the design of a future, fully-powered randomized controlled trial. REDD-CAT will allow clinical staff to preemptively link patients with community-based social services tailored to meet their unique needs in order to reduce avoidable hospitalization and emergency department visits.

NCT ID: NCT03889379 Withdrawn - Clinical trials for Immune Cell Composition

Albuterol and Immune Cell Composition

Start date: January 20, 2019
Phase: Early Phase 1
Study type: Interventional

The aim of this pilot study is to determine the effects of albuterol on the composition of immune cells in the bloodstream for possible future use in patients with neuroblastoma.